Benjamin Paluch

Stock Analyst at Roth MKM

(2.41)

# 2,329

Out of 4,786 analysts

3

Total ratings

66.67%

Success rate

10.08%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$26.42	+146.03%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$10.39	+63.62%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$3.08	+224.68%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $26.42

Upside: +146.03%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $10.39

Upside: +63.62%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $3.08

Upside: +224.68%